Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study.
Anna PlymAnna L V JohanssonHannah BowerAnna-Karin WennstigIrma FredrikssonJohan AhlgrenMats LambePublished in: Breast cancer research and treatment (2020)
Our findings of increased long-term risks of sick leave after oncological treatment for breast cancer warrant attention from caregivers taking part in cancer rehabilitation. In light of the ongoing debate about overtreatment of early-stage breast cancer, our findings point to the importance of properly selecting patients for chemotherapy not only for the medical toxicity but also the possible impact on their livelihood.
Keyphrases
- early stage
- locally advanced
- end stage renal disease
- sentinel lymph node
- rectal cancer
- healthcare
- newly diagnosed
- ejection fraction
- childhood cancer
- prostate cancer
- radiation therapy
- oxidative stress
- papillary thyroid
- young adults
- squamous cell carcinoma
- stem cells
- patient reported outcomes
- risk assessment
- neoadjuvant chemotherapy
- radiation induced
- combination therapy
- lymph node
- patient reported
- cell therapy
- robot assisted